- MDXH · Nasdaq
- Services-Medical Laboratories
- Herstal, C9
- 364 employees
- CIK 0001872529
Updated from SEC filings through
Top things to know
Executives
- Michael McGarrity Chief Executive Officer Form 4, June 3, 2026
- Ron Kalfus Chief Financial Officer Form 3, April 13, 2026
- John Bellano Chief Commercial Officer Form 4, June 3, 2026
- Brendan OConnell VP, Finance and Accounting Form 4, June 3, 2026
MDxHealth SA is a U.S. public company in services-medical laboratories (SIC 8071), headquartered in Herstal, C9. It trades as MDXH on Nasdaq. Revenue was $108M in the fiscal year ending December 31, 2025, +19.8% from the year before. It reported about 364 employees. Michael McGarrity is Chief Executive Officer.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $108M 20-F, 2026-04-03 | $90.0M 20-F, 2026-04-03 | $70.2M 20-F, 2026-04-03 | $37.1M 20-F, 2025-03-31 | $22.2M 20-F, 2024-04-30 |
| Operating income | -$14.4M 20-F, 2026-04-03 | -$24.7M 20-F, 2026-04-03 | -$27.3M 20-F, 2026-04-03 | -$37.9M 20-F, 2025-03-31 | -$26.8M 20-F, 2024-04-30 |
| SG&A | Not on file | Not on file | Not on file | Not on file | Not on file |
| Net income | -$33.5M 20-F, 2026-04-03 | -$38.1M 20-F, 2026-04-03 | -$43.1M 20-F, 2026-04-03 | -$44.0M 20-F, 2025-03-31 | -$29.0M 20-F, 2024-04-30 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Michael McGarrity Chief Executive Officer, Executive and Managing Director MDxHealth, Inc. | Chief Executive Officer | Form 4, June 3, 2026 |
| Ron Kalfus Strategic Finance Leader & CPA | IPO (NASDAQ) & SEC Reporting Specialist | Private Equity, M&A, and Business Transformation | Chief Financial Officer | Form 3, April 13, 2026 |
| John Bellano Healthcare Commercial Executive | Diagnostics & Precision Medicine | Growth, Revenue Cycle, Integration & Enterprise Execution | Chief Commercial Officer | Form 4, June 3, 2026 |
| Brendan OConnell | VP, Finance and Accounting | Form 4, June 3, 2026 |
What MDxHealth SA does
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases.com/company/mdxhealth.
Press release "About" paragraph, 10-K for the year ending October 16, 2026
Shares and governance
| Shares outstanding | 51.4 million (as of December 31, 2025) | 20-F, April 3, 2026 |
|---|---|---|
| Auditor | BDO Réviseurs d’Entreprises SRL (Zaventem, Belgium) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| August 13, 2026 | Eric Bednarski Director | Buy | 2,202,643 | $991K | Form 4, August 17, 2026 |
| August 13, 2026 | Partners LLC MVM Director | Buy | 2,202,643 | $991K | Form 4, August 17, 2026 |
Recent 8-K events
No 8-K filings on file.
Frequently asked questions about MDxHealth SA
- What does MDxHealth SA do?
- In its own words, from Item 1 of its 10-K: "Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases.com/company/mdxhealth."
- What is MDxHealth SA's revenue?
- $108M for the fiscal year ending December 31, 2025, from its 20-F filed April 3, 2026.
- Is MDxHealth SA profitable?
- MDxHealth SA reported net income of -$33.5M for the fiscal year ending December 31, 2025.
- How many employees does MDxHealth SA have?
- About 364 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of MDxHealth SA?
- Michael McGarrity, Chief Executive Officer, as named in a 4 filed June 3, 2026.
- Who is the CFO of MDxHealth SA?
- Ron Kalfus, Chief Financial Officer, as named in a 3 filed April 13, 2026.
- Where is MDxHealth SA headquartered?
- Herstal, C9.
- What is MDxHealth SA's stock ticker?
- MDXH on Nasdaq.
- What industry is MDxHealth SA in?
- Services-Medical Laboratories, SIC code 8071.
- What is MDxHealth SA's website?
- mdxhealth.com.
- When does MDxHealth SA report earnings next?
- February 11, 2027. This is an estimate from past filing dates, not a confirmed date.
- Is MDxHealth SA a public company?
- Yes. MDxHealth SA files with the SEC under CIK 0001872529 and trades as MDXH.
- Who audits MDxHealth SA?
- BDO Réviseurs d’Entreprises SRL, Zaventem, Belgium, as named in its latest annual report (10-K).
- How many shares of MDxHealth SA are outstanding?
- 51.4 million shares as of December 31, 2025, from its 20-F filed April 3, 2026.
- Have MDxHealth SA insiders traded stock recently?
- Since August 13, 2026, officers and directors reported 0 open-market sales and 2 purchases worth about $2.0M on Forms 4 and 5. The most recent: Eric Bednarski (Director) bought 2,202,643 shares on August 13, 2026.